WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 7 fonti

GC Biopharma sells US vaccine unit to Eli Lilly in $1.5b deal

GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem

Raccontata daqz.comendpoints.newscnbc.compharmaceutical-technology.comaxios.comupi.comkoreaherald.com

Confronto fonti

6 prospettive sulla stessa storia
AI · summaries
koreaherald.comStai leggendo17 h fa

GC Biopharma sells US vaccine unit to Eli Lilly in $1.5b deal

GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem

originale

Timeline cronologica

  1. martedì 26 maggio 2026·qz.com

    Eli Lilly acquires three vaccine developers for $3.8 billion

    The deals give Lilly vaccines targeting shingles, bacterial pathogens, and Epstein-Barr virus as it expands beyond weight loss drugs

  2. martedì 26 maggio 2026·endpoints.news

    Three vaccine biotechs to be bought by Lilly for up to $3.8B

    Lilly is making three acquisitions at once on Tuesday, for up to $3.8 billion total, to increase its presence in infectious disease. The pharma is buying Curevo, LimmaTech…

upi.com
1 g fa

Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - UPI.com

Eli Lilly announced Tuesday that it is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine Company, Inc., in deals totaling nearly $4 billion.

Leggi questa versione → originale
cnbc.com1 g fa

Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

Leggi questa versione → originale
pharmaceutical-technology.com1 g fa

Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology

Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.

Leggi questa versione → originale
endpoints.news1 g fa

Three vaccine biotechs to be bought by Lilly for up to $3.8B

Lilly is making three acquisitions at once on Tuesday, for up to $3.8 billion total, to increase its presence in infectious disease. The pharma is buying Curevo, LimmaTech Biologics and Vaccine Company.

Leggi questa versione → originale
qz.com1 g fa

Eli Lilly acquires three vaccine developers for $3.8 billion

The deals give Lilly vaccines targeting shingles, bacterial pathogens, and Epstein-Barr virus as it expands beyond weight loss drugs

Leggi questa versione → originale
  • martedì 26 maggio 2026·cnbc.com

    Eli Lilly stock edges higher as company plans nearly $4 billion in vaccine deals

    The deals are part of Eli Lilly’s effort to expand into infectious disease research and development.

  • martedì 26 maggio 2026·pharmaceutical-technology.com

    Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology

    Via the deals, Lilly is buying biotechs with lead programmes in preventing shingles, bacteria, and Epstein-Barr Virus.

  • martedì 26 maggio 2026·axios.com

    Eli Lilly spending $3.8 billion to buy vaccine makers

    GLP-1 riches are being repurposed to prevent infections.

  • martedì 26 maggio 2026·upi.com

    Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - UPI.com

    Eli Lilly announced Tuesday that it is acquiring Curevo Inc., LimmaTech Biologics AG and Vaccine Company, Inc., in deals totaling nearly $4 billion.

  • mercoledì 27 maggio 2026·koreaherald.com

    GC Biopharma sells US vaccine unit to Eli Lilly in $1.5b deal

    GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem